Please login to the form below

Not currently logged in
Email:
Password:

LY-CoV555

This page shows the latest LY-CoV555 news and features for those working in and with pharma, biotech and healthcare.

Eli Lilly reports first results for COVID-19 targeting antibody

Eli Lilly reports first results for COVID-19 targeting antibody

Also, in exploratory analyses, Lilly added that LY-CoV555 seemed to improve COVID-19 symptoms at a faster rate compared to those who did not receive the antibody treatment. ... Although the results are promising, a larger confirmatory trial is needed to

Latest news

  • Eli Lilly begins COVID-19 prevention trial in nursing homes Eli Lilly begins COVID-19 prevention trial in nursing homes

    Eli Lilly has initiated a phase 3 trial of its monoclonal antibody (mAb) LY-CoV555 for the prevention of the novel coronavirus in nursing homes across the US. ... LY-CoV555 is the result of this early screening, and is now the lead candidate from

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Iguazu

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics